Results 271 to 280 of about 12,125,138 (354)

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine   +10 more
wiley   +1 more source

Saving Retirement in the USA [PDF]

open access: yes, 2014
Isakova, M.L., Zahorulko, Kostiantyn
core  

Publisher Correction: ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27. [PDF]

open access: yesNat Commun
Wang Y   +13 more
europepmc   +1 more source

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte   +10 more
wiley   +1 more source

USA. Finanskrisen sætter lighed på dagsordenen [PDF]

open access: yes, 2013
Kjærsgård, Andreas Pihl
core  

Correction: Transitioning from the Safety of the Womb to the Outside World for Neonates with Life-Threatening Cardiovascular Conditions: The IMmediate Postpartum Access to Cardiac Therapy (IMPACT) Procedure. [PDF]

open access: yesPediatr Cardiol
Padiyath A   +11 more
europepmc   +1 more source

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

open access: yesMolecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy